Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
fda
life sciences
national blog main
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alexion pharmaceuticals
allergan
american academy of neurology
american society of clinical oncology (asco)
amgen
amyotrophic lateral sclerosis (als)
anti-inflammatory drugs
arcturus therapeutics
atogepant
What
drug
3
×
potential
3
×
meeting
ahead
alternative
ambien
american
annual
approval
arguments
asco
attendees
attention
autoimmune
big
biotech
camp’s
cancer
candidate
cash
chicago
city
class
clinical
combinations
commercialized
community’s
companies
competitors
days
deal
decades
disease
drugs
expanding
expensive
fda
focus
home
key
Language
unset
Current search:
potential
×
drug
×
" boston blog main "
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
